O

OCON Therapeutics

22 employees

Our mission is to introduce innovative, high-quality an intrauterine drug-delivery technology to improve women’s health and quality of life

Basic info

Industry

pharmaceutical manufacturing

Sectors

Women's Health
hormone-free contraception
Non-hormonal contraception
Women's Lifestyle
LARC
hysterectomy
The SEAD
innovative contraception
non surgical therapy
AUB
OBGYN
family planning
baby planning
ball contraception
IUB
IUD
sexual health
Abnormal uterine bleeding
Gynecology
GP
Contraception
Pharmaceutical
Drug Products
bio investments
birth control
Health Care
Ballerine
Intrauterine
Healthcare

Date founded

2020

Funding rounds raised

Total raised

$15M

from 4 investors over 4 rounds

O

OCON Therapeutics raised $4.5M on December 31, 2020

Investors: Merchavia Holdings and Investments Ltd and Rhia Ventures

O

OCON Therapeutics raised $15M on January 29, 2016

Investors: DOCOR and Pontifax Venture Capital

FAQ